INS and Alzheimer disease: One proposed therapeutic approach to AD is direct delivery of insulin to the brain, following multiple lines of study that suggest that dysregulation of brain insulin production, delivery, receptor binding, signaling, and/or downstream events may be dysregulated along the pathway to AD [2-11].